Charge-Reversed Lipid Nanoparticles Enable Encapsulation of Pt2L4 Nanocages for In vivo Anti-Cancer Treatment.
Re-engineer lipid nanoparticles into charge-reversed lipid nanoparticles (revLNPs) capable of efficiently encapsulating cationic Pt2L4 nanocages and establish revLNPs as a broadly applicable delivery platform that overcomes solubility, biodistribution, and pharmacokinetic barriers of cationic inorganic drugs, enabling...